The identification and validation of Auger electron-emitting radiopharmaceuticals targeting telomerase for cancer therapy
<p>Telomerase is expressed in the majority (>85%) of tumours but not in differentiated normal tissue. This enzyme catalyses the elongation of telomeres – a process critical for continued cell proliferation. Telomerase is a potential novel target for molecularly-targeted radiotherapy (mR...
Κύριος συγγραφέας: | Jackson, M |
---|---|
Άλλοι συγγραφείς: | Vallis, K |
Μορφή: | Thesis |
Γλώσσα: | English |
Έκδοση: |
2013
|
Θέματα: |
Παρόμοια τεκμήρια
-
Selective targeting of homologous recombination deficiency
ανά: Zimmer, J
Έκδοση: (2014) -
Targeting EGFR signalling pathway in triple negative breast cancer
ανά: Albukhari, A
Έκδοση: (2014) -
Targeting EGFR signalling pathway in triple negative breast cancer
ανά: Albukhari, A
Έκδοση: (2014) -
Development of models and methods to assess the efficacy of anti-cancer drugs targeted to the mitochondria
ανά: Potter, M
Έκδοση: (2014) -
Radiopharmaceutical Validation for Clinical Use
ανά: Charles A. Kunos, κ.ά.
Έκδοση: (2021-03-01)